Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma

<p><b>Background</b></p> Mepolizumab is an anti-interleukin-5 monoclonal antibody treatment for severe eosinophilic asthma (SEA) that reduces asthma exacerbations. Residual airway inflammation on mepolizumab may lead to persistent exacerbations. Oral corticosteroids remain th...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Howell, I, Yang, F, Brown, V, Cane, J, Marchi, E, Azim, A, Busby, J, McDowell, PJ, Diver, SE, Borg, C, Heaney, LG, Pavord, ID, Brightling, CE, Chaudhuri, R, Hinks, TSC
स्वरूप: Journal article
भाषा:English
प्रकाशित: Elsevier 2024